Azaindoles useful as inhibitors of janus kinases
US-2016008359-A1 · Jan 14, 2016 · US
US10039762B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10039762-B2 |
| Application number | US-201715718186-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 28, 2017 |
| Priority date | Jun 17, 2009 |
| Publication date | Aug 7, 2018 |
| Grant date | Aug 7, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Opening claim text (preview).
What is claimed is: 1. A method preparing a compound of formula 1070: or a pharmaceutically acceptable salt thereof, comprising the steps of: i) reacting a compound having the formula: with to form a compound having the formula: and ii) deprotecting the tosyl group to form the compound of formula 1070 or a pharmaceutically acceptable salt thereof. 2. A method preparing a compound of formula 1070: or a pharmaceutically acceptable salt thereof, comprising the steps of: i) reacting a compound of formula with a compound of formula to form a compound having the formula: and ii) deprotecting the tosyl group to form the compound of formula 1070 or a pharmaceutically acceptable salt thereof.
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Immunostimulants · CPC title
for influenza or rhinoviruses · CPC title
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
linked by a carbon chain containing aromatic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.